Minimal Residual Disease Measured after Treatment with Bispecifics in Relapsed Multiple Myeloma: Experience from an Academic Medical Center

被引：0
|
作者：
Blanco, Alberto [1 ]
Chari, Ajai [2 ]
Martin, Thomas G. [2 ]
Arora, Shagun [2 ]
Chung, Alfred [2 ]
Kumar, Anupama Deepa [2 ]
Shah, Nina [2 ]
Wong, Sandy W. [2 ]
Takamatsu, Hiroyuki [3 ]
Martinez-Lopez, Joaquin [1 ]
Wolf, Jeffrey Lee [2 ]
机构：
[1] Hosp Univ 12 Octubre, Dept Hematol, Madrid, Spain
[2] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA USA
[3] Kanazawa Univ, Dept Hematol, Kanazawa, Japan
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203768
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7020 / 7021
页数：2
相关论文
共 50 条
  • [31] Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience
    Minnema, M. C.
    van Dorp, S.
    de Donk, N. W. C. J. van
    Schouten, F.
    Kersten, M. J.
    Coenen, J. L. L. M.
    Schouten, H.
    Zweegman, S.
    Schaafsma, R.
    Lokhorst, H. M.
    BONE MARROW TRANSPLANTATION, 2011, 46 (02) : 244 - 249
  • [32] Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience
    M C Minnema
    S van Dorp
    N W C J van de Donk
    F Schouten
    M J Kersten
    J L L M Coenen
    H Schouten
    S Zweegman
    R Schaafsma
    H M Lokhorst
    Bone Marrow Transplantation, 2011, 46 : 244 - 249
  • [33] FLOW CYTOMETRIC MINIMAL RESIDUAL DISEASE MONITORING IN MULTIPLE MYELOMA AFTER BONE MARROW ALLOGENIC TRANSPLANTATION
    Safra, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 612 - 612
  • [34] Monitoring of minimal residual disease among multiple myeloma patients after autologous stem cell transplantation
    Akhundova, F.
    Mendeleeva, L.
    Galtseva, I.
    Pokrovskaya, O.
    Urnova, E.
    Parovichnikova, E.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S258 - S259
  • [35] Stem Cell Autograft Minimal Residual Disease Negativity Improves Outcomes after Autotransplant for Multiple Myeloma
    Nishimura, Noriko
    Brown, Samantha
    Devlin, Sean M.
    Dahi, Parastoo B.
    Landau, Heather
    Lahoud, Oscar B.
    Scordo, Michael
    Shah, Gunjan L.
    Hassoun, Hani
    Hultcrantz, Malin
    Korde, Neha
    Lesokhin, Alexander M.
    Mailankody, Sham
    Shah, Urvi A.
    Tan, Carlyn
    Usmani, Saad
    Giralt, Sergio A.
    Chung, David J.
    Gupta, Gaurav
    Maryamchik, Elena
    Ntrivalas, Evangelos
    Roshal, Mikhail
    BLOOD, 2022, 140
  • [36] MAINTENANCE THERAPY WITH BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA (MM) AFTER ASCT AND MINIMAL RESIDUAL DISEASE (MRD)
    Solovev, M.
    Mendeleeva, L.
    Pokrovskaya, O.
    Gemdzhian, E.
    Galtseva, I.
    Davydova, J.
    Firsova, M.
    Nareyko, M.
    Abramova, T.
    Savchenko, V.
    HAEMATOLOGICA, 2017, 102 : 531 - 531
  • [37] Multiple myeloma: Maintenance therapy after autologous stem cell transplantation, depending on minimal residual disease
    Solovyev, M. V.
    Mendeleeva, L. P.
    Pokrovskaya, O. S.
    Nareyko, M. V.
    Firsova, M. V.
    Galtseva, I. V.
    Davydova, Yu. O.
    Kapranov, N. M.
    Kuzmina, L. A.
    Gemdzhian, E. G.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (07) : 25 - 31
  • [38] Characterization of minimal residual disease (MRD) in patients with relapsed/refractory multiple myeloma treated with elranatamab: analysis of MagnetisMM-3
    Touzeau, Cyrille
    Weisel, Katja
    Bahlis, Nizar
    Quach, Hang
    Hamilton, Finn
    Wang, Shen-wu
    Leip, Eric
    Viqueira, Andrea
    O'Brien, Thomas
    Rodriguez-Otero, Paula
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S82 - S83
  • [39] Flow cytometry immunophenotype is a powerful approach in monitoring minimal residual disease and treatment efficacy in multiple myeloma
    Cordone, I.
    Masi, S.
    Pasquale, A.
    Pisani, F.
    Olimpieri, O. M.
    Marino, M.
    D'Andrea, M.
    Dessanti, M. L.
    Petti, M. C.
    CYTOMETRY PART A, 2008, 73A (01) : 79 - 79
  • [40] Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
    Rawstron, Andy C.
    Child, J. Anthony
    de Tute, Ruth M.
    Davies, Faith E.
    Gregory, Walter M.
    Bell, Sue E.
    Szubert, Alexander J.
    Navarro-Coy, Nuria
    Drayson, Mark T.
    Feyler, Sylvia
    Ross, Fiona M.
    Cook, Gordon
    Jackson, Graham H.
    Morgan, Gareth J.
    Owen, Roger G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2540 - +
12345